Celaid Therapeutics will be attending the BIO International Convention 2026, taking place in San Diego, California, USA, from June 22 to 25, 2026. Celaid Therapeutics has been selected as one of 24 companies to exhibit in the Japan Pavilion organized by JETRO (Booth #4421, Company Booth #06).
The BIO International Convention is one of the world's largest biotechnology events, bringing together leading pharmaceutical and biotechnology companies, investors, research institutions, and other key stakeholders from across the global life sciences industry.
During the convention, Celaid Therapeutics will showcase CLD-001, its hematopoietic stem cell transplantation product currently under development in the United States, as well as its proprietary hematopoietic stem cell platform technologies. We look forward to exploring opportunities for strategic partnerships, co-development collaborations, and licensing discussions with pharmaceutical companies, biotechnology companies, and research institutions worldwide.
If you would like to schedule a meeting with our team during BIO 2026, please contact us through the BIO Partnering™ system or via the inquiry form on our website. Walk-ins to our booth are also welcome.
We look forward to engaging in meaningful discussions and exploring potential collaboration opportunities with industry partners.
